TGFB1 and neoplasm: In the prostate, this path is followed via a transformation of the TGF-β signaling—a proliferation inhibitor and apoptosis inducer in the normal epithelium—into a tumor-promoting mechanism that acts extraepithelially through neoangiogenesis, extracellular matrix remodeling, and immunosuppression [85].